Results 121 to 130 of about 71,068 (268)

Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome

Arthritis Care &Research, EarlyView.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino, Grant W. Cannon, Brian C. Sauer, Jorge Rojas, Gregory J. Stoddard, Gary A. Kunkel, Jessica A. Walsh, Bryant R. England, Joshua F. Baker, Tawnie J. Braaten   +9 more
wiley   +1 more source

From public healthcare centers to community pharmacies: the new Portuguese seasonal vaccination strategy. [PDF]

Front Public Health
Goiana-da-Silva F, Peralta-Santos A, Cabral M, Tude-Graça D, Tamudjim-Fonseca P, Pinheiro-Guedes L, Morais-Vilaça I, Costa D, Cardoso S, Dionísio J, Ornelas M, Vasconcelos R, Sá J, Guedes R, Costa S, Malcata F, Moreira R, Cardoso F, Alves J, Azevedo J, Cortez I, Paulino E, Mota-Filipe H, Santos Ivo R, Sá Machado R, Breda J, Ashrafian H, Pizarro M, Darzi A.   +28 more
europepmc   +1 more source

Effect of Implementing a Dashboard With or Without a Best Practice Alert on HLA‐B*58:01 Testing Rates Among Allopurinol Users at VA Medical Centers

Arthritis Care &Research, EarlyView.
Objective The American College of Rheumatology recommends HLA‐B*58:01 allele testing before the initiation of allopurinol, specifically among Asian and African American/Black patients, due to their increased risk for severe hypersensitivity reactions. However, testing rates remain low at many health care facilities.
Abimbola Fadairo‐Azinge, Gabriela Schmajuk, Sristi Sharma, Colleen P. Flanagan, Sara Faghihi‐Kashani, Ning Zhang, Mary A. Whooley   +6 more
wiley   +1 more source

APOSCREEN-1 - a prospective, single-arm clinical trial for the implementation of a pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-Holstein. [PDF]

BMC Nephrol
Amelunxen E, Kokot A, Kolbrink B, Thomsen SY, Meßtorff ML, Laudes M, Lienhard KR, Bachmann LM, Sievers LK, Schmitt R, Schulte K, von Samson-Himmelstjerna FA.   +11 more
europepmc   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

Arthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya, Sandra G. Williams, Raphael A. Kirou, Marissa Lightbourne, Rebecca J. Brown   +4 more
wiley   +1 more source

Efficient engagement: opportunities for mobile methadone maintenance in geographically underserved areas. [PDF]

Health Care Manag Sci
Bonifonte A, Garcia E, Soth S, Ngo H.
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Point-of-care testing in community pharmacies to improve antimicrobial stewardship in respiratory infections: a scoping review of effectiveness, implementation and cost-effectiveness. [PDF]

JAC Antimicrob Resist
Saha SK, Promite S, Botheras CL, Manias E, Mothobi N, Robinson S, Athan E.   +6 more
europepmc   +1 more source

Pharmacy. Industrial pharmacy

, 2023
Idil, Varol, Lapuzina, O.
openaire   +1 more source

Pharmacy's Directions: 1. Pharmacies and Drugstores [PDF]

Annals of Pharmacotherapy, 2006
openaire   +1 more source